Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01637987 · ClinicalTrials.gov registry record · NA
Nurse PIV Insertion Success With and Without Assistive Devices in Patients 0-12 Months of Age
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 104
- Enrollment target
NCT01637987: Clinical Trial NA study, sponsored by University of Nebraska.
NCT01637987 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01637987, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of a vein identification assistive device increases nurse PIV insertion success within the first two attempts in children 0-12 months of age when compared to unassisted methods.
Primary Outcome
Success = Insertion of a 22 or 24-gauge catheter into a peripheral vein followed by the immediate ability to flush 1-2 ml normal saline without signs of venous infiltration (e.g., pain and swelling). Failure = Inability to insert a 22 or 24-gauge catheter into a peripheral vein, or insertion of a catheter into a peripheral vein followed by the immediate inability to flush 1-2 ml normal saline or signs of infiltration upon flushing.
Interventions
- PROCEDURE Unassisted vein visualization
- PROCEDURE Wee Sight® Transilluminator
- PROCEDURE VeinViewer® (Christie Digital Systems, Cypress, CA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2012-07-01 |
| Est. Completion | 2017-02-02 |
| Phase | NA |
Why NCT01637987 stopped before completion
NCT01637987 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Unassisted vein visualization is the first listed.
NCT01637987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01637987 about?
NCT01637987 is a clinical study titled "Nurse PIV Insertion Success With and Without Assistive Devices in Patients 0-12 Months of Age". The purpose of this study is to determine if the use of a vein identification assistive device increases nurse PIV insertion success within the first two attempts in children 0-12 months of age when compared to unassisted methods.
What is the current status of trial NCT01637987?
This trial is currently terminated. It is a NA study. The enrollment target is 104 participants. The study started on 2012-07-01. Estimated completion is 2017-02-02.
What interventions are being tested in trial NCT01637987?
The interventions under investigation include: Unassisted vein visualization (PROCEDURE), Wee Sight® Transilluminator (PROCEDURE), VeinViewer® (Christie Digital Systems, Cypress, CA) (PROCEDURE).
Who is sponsoring clinical trial NCT01637987?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01637987's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI